FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1050716511> ?p ?o ?g. }

• W1050716511 endingPage "808" @default.
• W1050716511 startingPage "801" @default.
• W1050716511 abstract "To assess the technical feasibility, toxicity, dosimetry, and preliminary efficacy of dose-painting brachytherapy guided by ultrasound spectrum analysis tissue-type imaging (TTI) in low-risk, localized prostate cancer.Fourteen men with prostate cancer who were candidates for brachytherapy as sole treatment were prospectively enrolled. Treatment planning goal was to escalate the tumor dose to 200% with a modest de-escalation of dose to remaining prostate compared with our standard. Primary end points included technical feasibility of TTI-guided brachytherapy and equivalent or better toxicity compared with standard brachytherapy. Secondary end points included dose escalation to tumor regions and de-escalated dose to nontumor regions on the preimplant plan, negative prostate biopsy at 2 years, and freedom from biochemical failure.Thirteen of fourteen men successfully completed the TTI-guided brachytherapy procedure for a feasibility rate of 93%. A software malfunction resulted in switching one patient from TTI-guided to standard brachytherapy. An average of 2.7 foci per patient was demonstrated and treated with an escalated dose. Dosimetric goals on preplan were achieved. One patient expired from unrelated causes 65 days after brachytherapy. Toxicity was at least as low as standard brachytherapy. Two-year prostate biopsies were obtained from six men; five (83%) were definitively negative, one showed evidence of disease with treatment effect, and none were positive. No patients experienced biochemical recurrence after a median followup of 31.5 (24-52) months.We have demonstrated that TTI-guided dose-painting prostate brachytherapy is technically feasible and results in clinical outcomes that are encouraging in terms of low toxicity and successful biochemical disease control." @default.
• W1050716511 created "2016-06-24" @default.
• W1050716511 creator A5020590146 @default.
• W1050716511 creator A5030215699 @default.
• W1050716511 creator A5030221717 @default.
• W1050716511 creator A5038100918 @default.
• W1050716511 creator A5042787185 @default.
• W1050716511 creator A5043177295 @default.
• W1050716511 creator A5055863112 @default.
• W1050716511 creator A5075355262 @default.
• W1050716511 creator A5080360470 @default.
• W1050716511 date "2015-11-01" @default.
• W1050716511 modified "2023-10-11" @default.
• W1050716511 title "Phase I/II prospective trial of cancer-specific imaging using ultrasound spectrum analysis tissue-type imaging to guide dose-painting prostate brachytherapy" @default.
• W1050716511 cites W1980600130 @default.
• W1050716511 cites W1987213359 @default.
• W1050716511 cites W1995830749 @default.
• W1050716511 cites W1999045406 @default.
• W1050716511 cites W2023984355 @default.
• W1050716511 cites W2029725065 @default.
• W1050716511 cites W2030925834 @default.
• W1050716511 cites W2035768410 @default.
• W1050716511 cites W2040839781 @default.
• W1050716511 cites W2042478008 @default.
• W1050716511 cites W2054527786 @default.
• W1050716511 cites W2078968196 @default.
• W1050716511 cites W2091974072 @default.
• W1050716511 cites W2093867637 @default.
• W1050716511 cites W2101001966 @default.
• W1050716511 cites W2104377080 @default.
• W1050716511 cites W2108014935 @default.
• W1050716511 cites W2112285253 @default.
• W1050716511 cites W2118157857 @default.
• W1050716511 cites W2123284539 @default.
• W1050716511 cites W2132106774 @default.
• W1050716511 cites W2135369558 @default.
• W1050716511 cites W2143057476 @default.
• W1050716511 cites W2143962930 @default.
• W1050716511 cites W2144841219 @default.
• W1050716511 cites W2147251906 @default.
• W1050716511 cites W2147303790 @default.
• W1050716511 cites W2159943338 @default.
• W1050716511 cites W2167053110 @default.
• W1050716511 cites W2327802402 @default.
• W1050716511 doi "https://doi.org/10.1016/j.brachy.2015.06.011" @default.
• W1050716511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26235201" @default.
• W1050716511 hasPublicationYear "2015" @default.
• W1050716511 type Work @default.
• W1050716511 sameAs 1050716511 @default.
• W1050716511 citedByCount "6" @default.
• W1050716511 countsByYear W10507165112016 @default.
• W1050716511 countsByYear W10507165112017 @default.
• W1050716511 countsByYear W10507165112020 @default.
• W1050716511 countsByYear W10507165112022 @default.
• W1050716511 crossrefType "journal-article" @default.
• W1050716511 hasAuthorship W1050716511A5020590146 @default.
• W1050716511 hasAuthorship W1050716511A5030215699 @default.
• W1050716511 hasAuthorship W1050716511A5030221717 @default.
• W1050716511 hasAuthorship W1050716511A5038100918 @default.
• W1050716511 hasAuthorship W1050716511A5042787185 @default.
• W1050716511 hasAuthorship W1050716511A5043177295 @default.
• W1050716511 hasAuthorship W1050716511A5055863112 @default.
• W1050716511 hasAuthorship W1050716511A5075355262 @default.
• W1050716511 hasAuthorship W1050716511A5080360470 @default.
• W1050716511 hasConcept C121608353 @default.
• W1050716511 hasConcept C126322002 @default.
• W1050716511 hasConcept C126838900 @default.
• W1050716511 hasConcept C201645570 @default.
• W1050716511 hasConcept C2776235491 @default.
• W1050716511 hasConcept C2777416452 @default.
• W1050716511 hasConcept C2778648096 @default.
• W1050716511 hasConcept C2780192828 @default.
• W1050716511 hasConcept C2989005 @default.
• W1050716511 hasConcept C509974204 @default.
• W1050716511 hasConcept C71924100 @default.
• W1050716511 hasConcept C75088862 @default.
• W1050716511 hasConceptScore W1050716511C121608353 @default.
• W1050716511 hasConceptScore W1050716511C126322002 @default.
• W1050716511 hasConceptScore W1050716511C126838900 @default.
• W1050716511 hasConceptScore W1050716511C201645570 @default.
• W1050716511 hasConceptScore W1050716511C2776235491 @default.
• W1050716511 hasConceptScore W1050716511C2777416452 @default.
• W1050716511 hasConceptScore W1050716511C2778648096 @default.
• W1050716511 hasConceptScore W1050716511C2780192828 @default.
• W1050716511 hasConceptScore W1050716511C2989005 @default.
• W1050716511 hasConceptScore W1050716511C509974204 @default.
• W1050716511 hasConceptScore W1050716511C71924100 @default.
• W1050716511 hasConceptScore W1050716511C75088862 @default.
• W1050716511 hasIssue "6" @default.
• W1050716511 hasLocation W10507165111 @default.
• W1050716511 hasLocation W10507165112 @default.
• W1050716511 hasOpenAccess W1050716511 @default.
• W1050716511 hasPrimaryLocation W10507165111 @default.
• W1050716511 hasRelatedWork W1988957623 @default.
• W1050716511 hasRelatedWork W1989069219 @default.
• W1050716511 hasRelatedWork W1994180560 @default.
• W1050716511 hasRelatedWork W2027294118 @default.
• W1050716511 hasRelatedWork W2039692113 @default.

• next